rs2870984
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PS1_ModerateBP4_StrongBS1_SupportingBS2
The NM_016335.6(PRODH):c.1397C>T(p.Thr466Met) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T466K) has been classified as Uncertain significance.
Frequency
Consequence
NM_016335.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRODH | NM_016335.6 | c.1397C>T | p.Thr466Met | missense_variant | 11/14 | ENST00000357068.11 | |
PRODH | NM_001195226.2 | c.1073C>T | p.Thr358Met | missense_variant | 11/14 | ||
PRODH | NM_001368250.2 | c.1073C>T | p.Thr358Met | missense_variant | 11/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRODH | ENST00000357068.11 | c.1397C>T | p.Thr466Met | missense_variant | 11/14 | 1 | NM_016335.6 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00370 AC: 103AN: 27870Hom.: 1 Cov.: 5
GnomAD3 exomes AF: 0.00463 AC: 1160AN: 250538Hom.: 11 AF XY: 0.00481 AC XY: 651AN XY: 135446
GnomAD4 exome AF: 0.00481 AC: 929AN: 193086Hom.: 26 Cov.: 0 AF XY: 0.00490 AC XY: 500AN XY: 102144
GnomAD4 genome AF: 0.00372 AC: 104AN: 27954Hom.: 1 Cov.: 5 AF XY: 0.00399 AC XY: 51AN XY: 12788
ClinVar
Submissions by phenotype
Proline dehydrogenase deficiency Pathogenic:2Benign:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2007 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Groupe Hospitalier Pitie Salpetriere, UF Genomique du Developpement, Assistance Publique Hopitaux de Paris | Jan 06, 2017 | Intellectual disability; epilepsy; schizophrenia - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | PRODH: BS1, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2020 | See Variant Classification Assertion Criteria. - |
Schizophrenia 4 Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Oct 01, 2007 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at